Table 4. Prevention.

Previous treatment of osteoporosis and primary prevention as well as Secondary prevention of osteoporotic fractures and its associated fractures.

Age Group	Previously Diagnosed Osteoporosis		Intake of Specific Medication		Gender Differences (p-value)	Treatment / Prevention with General Practitioner		Treatment / Prevention with specialized Consultant		Gender Differences (p-value)
	female	male	female	male		female	male	female	male
50–59	11	1	5	1	p = 0.124	3 (1%)	1 (0.5%)	11 (2%)	1 (0.5%)	p = 0.145
60–69	30	2	12	0	p = 0.010	18 (3%)	0	47 (9.5%)	1 (0.5%)	p = 0.042
70–79	46	1	26	0	p = 0.011	11 (2%)	1 (0.5%)	31 (6.5%)	0	p = 0.079
80–89	50	0	22	0	n.s.*	0	0	22 (4%)	0	n.s.*
Over 90	11	0	1	0	n.s.*	0	0	6 (1%)	0	n.s.*